• Ontario cycling trek supports cancer research • Team raised nearly $177,000, more than doubling the amount collected last year • Magna matching donations

AURORA, Ontario, June 12, 2017 - Magna employees transitioned from the office to the roads of Ontario on June 10-11 to raise money for cancer research during the 2017 Ride to Conquer Cancer, a two-day, 200- kilometre bike trek from Toronto to Niagara Falls to support The Princess Margaret Cancer Centre.

Throughout the first-half of the year, riders collected donations on their own prior to the ride. Magna matched the contributions through its Magna Matching Program, a program designed to enhance employee-led initiatives that support social and charitable causes. In addition, a number of Magna's business partners demonstrated their support of the cycling team's efforts, with 100% of their funds going directly to The Princess Margaret Cancer Centre. This year's efforts raised a total of nearly $177,000, exceeding a goal set by the riders of doubling the amount from last year's ride.

Team Magna at the 2017 Ride to Conquer Cancer bike trek event.

'Magna is proud to help contribute to this terrific event and match funds collected for The Princess Margaret Cancer Centre,' said Marc Neeb, Chief Human Resource Officer at Magna International. 'I see the dedication of our employees who take on this grueling challenge and I applaud them for their efforts and determination to raise not only money but the continued awareness of a great cause.'

The Ride to Conquer Cancer has raised more than $155 million since 2008. Magna previously contributed $20,000 to the Princess Margaret Cancer Centre at the 2016 Road Hockey to Conquer Cancer event alongside BASF Canada.

Visit Team Magna's official team page to learn more about the ride and how you can help continue to support the team.

TAGS

Ride to Conquer Cancer, Princess Margaret Cancer Centre, social responsibility

INVESTOR CONTACT

Louis Tonelli, Vice-President, Investor Relations
louis.tonelli@magna.com, 905.726.7035

MEDIA CONTACT

Tracy Fuerst, Global Director Corporate Communications & Public Relations
tracy.fuerst@magna.com, 248.631.5396

ABOUT MAGNA

We are a leading global automotive supplier with 321 manufacturing operations and 102 product development, engineering and sales centres in 29 countries. We have over 159,000 employees focused on delivering superior value to our customers through innovative products and processes, and world class manufacturing. We have complete vehicle engineering and contract manufacturing expertise, as well as product capabilities which include body, chassis, exterior, seating, powertrain, active driver assistance, vision, closure and roof systems. We also have electronic and software capabilities across many of these areas. Our common shares trade on the Toronto Stock Exchange (MG) and the New York Stock Exchange (MGA). For further information about Magna, visit our website at www.magna.com.

# # #

THIS RELEASE MAY CONTAIN STATEMENTS WHICH CONSTITUTE 'FORWARDLOOKING STATEMENTS' UNDER APPLICABLE SECURITIES LEGISLATION AND ARE SUBJECT TO, AND EXPRESSLY QUALIFIED BY, THE CAUTIONARY DISCLAIMERS THAT ARE SET OUT IN MAGNA'S REGULATORY FILINGS. PLEASE REFER TO MAGNA'S MOST CURRENT MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL POSITION, ANNUAL INFORMATION FORM AND ANNUAL REPORT ON FORM 40-F, AS REPLACED OR UPDATED BY ANY OF MAGNA'S SUBSEQUENT REGULATORY FILINGS, WHICH SET OUT THE CAUTIONARY DISCLAIMERS, INCLUDING THE RISK FACTORS THAT COULD CAUSE ACTUAL EVENTS TO DIFFER MATERIALLY FROM THOSE INDICATED BY SUCH FORWARD-LOOKING STATEMENTS. THESE DOCUMENTS ARE AVAILABLE FOR REVIEW ON MAGNA'S WEBSITE AT WWW.MAGNA.COM.

Magna International Inc. published this content on 12 June 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 13 June 2017 00:59:12 UTC.

Original documenthttp://www.magna.com/media/press-releases-news/releases-news/2017/06/13/news-release---riding-toward-a-cure-magna-employees-bike-to-conquer-cancer

Public permalinkhttp://www.publicnow.com/view/A3EADF8317ED5118C38508EA24813A307C04FA40